{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05619627",
            "orgStudyIdInfo": {
                "id": "STUDY00002526"
            },
            "organization": {
                "fullName": "Children's Mercy Hospital Kansas City",
                "class": "OTHER"
            },
            "briefTitle": "Oral Dexmedetomidine in Pediatric MRI",
            "officialTitle": "Utility of Oral Dexmedetomidine as the Sole Sedative Agent in Pediatric Population Undergoing MRI",
            "therapeuticArea": [
                "Other"
            ],
            "study": "oral-dexmedetomidine-in-pediatric-mri"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-10-05",
            "studyFirstSubmitQcDate": "2022-11-16",
            "studyFirstPostDateStruct": {
                "date": "2022-11-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Children's Mercy Hospital Kansas City",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The objective of this preliminary study is to assess the utility of oral dexmedetomidine as the sole sedative agent in pediatric population undergoing MRI",
            "detailedDescription": "MRI is an important and robust medical imaging technique that has become the cornerstone for radiologic studies. Superior image quality and resolution especially for soft tissue imaging, without the use of ionizing radiation has made MRI one of the most dominant imaging modalities in pediatrics. Despite its many advantages, MRI is not child friendly. Lengthy scan times, the need for lying motionless in a confined space, excessive noise and vibration during image acquisition, are all factors that have made anesthesia an integral part of pediatric MRI.\n\nGeneral anesthesia is a state of medically induced unconsciousness, analgesia and muscle relaxation which is required for most invasive medical procedures. Despite being painless, imaging tests such as MRI scans are highly susceptible to motion artifact and require a state of immobility that may not be obtainable in awake uncooperative patients such as pediatrics. While very safe, general anesthesia carries potential risk of serious morbidity and mortality secondary to aspiration during instrumentation of the airway, hypoxia and hypoventilation secondary to laryngospasm/bronchospasm and hemodynamic instability. Therefore, sedation may be an appropriate technique to offer anxiolysis, amnesia and immobility while maintaining airway reflexes with limited impact on ventilation and hemodynamics for non-stimulating procedures such as imaging. Aside from having a more favorable risk/benefit profile compared to general anesthesia when it comes to radiologic studies, sedation is also less costly and burdensome on anesthesia departments and could provide immense cost-saving measures for healthcare institutions at large.\n\nWhile there are many intravenous (IV) sedatives, establishing an awake IV access could be very traumatizing and leave a lasting negative impression of the healthcare environment in a child's mind. Hence, enteral medications may be more acceptable and child friendly. This is especially valuable in patients who require repeated surveillance imaging and who demonstrate heightened level of anxiety and fear with each visit. Among sedative agents that could be administered enterally, dexmedetomidine may be superior due to minimal respiratory depression while providing anxiolysis and analgesia. Of note, dexmedetomidine is a highly selective alpha2-adrenoreceptor agonist that exerts its hypnotic action through activation of central pre- and postsynaptic alpha2-receptors in the locus coeruleus, mimicking natural sleep."
        },
        "conditionsModule": {
            "conditions": [
                "Anesthesia"
            ],
            "keywords": [
                "Oral dexmedetomidine",
                "Precedex"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Prospective Pilot Study, Single-site, open-label, phase I dose escalation trial",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 120,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dexmedetomidine 12 mcg/kg",
                    "type": "EXPERIMENTAL",
                    "description": "Group One: Subjects will receive oral dexmedetomidine 12 mcg/kg 2 hours prior to MRI",
                    "interventionNames": [
                        "Drug: Dexmedetomidine"
                    ]
                },
                {
                    "label": "Dexmedetomidine 18 mcg/kg",
                    "type": "EXPERIMENTAL",
                    "description": "Group Two: Subjects will receive oral dexmedetomidine 18 mcg/kg 2 hours prior to MRI",
                    "interventionNames": [
                        "Drug: Dexmedetomidine"
                    ]
                },
                {
                    "label": "Dexmedetomidine 24 mcg/kg",
                    "type": "EXPERIMENTAL",
                    "description": "Group Three: Subjects will receive oral dexmedetomidine 24 mcg/kg 2 hours prior to MRI",
                    "interventionNames": [
                        "Drug: Dexmedetomidine"
                    ]
                },
                {
                    "label": "General anesthesia control",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Control group: Subjects will receive general anesthesia for their MRI",
                    "interventionNames": [
                        "Drug: General anesthetic"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Dexmedetomidine",
                    "description": "Patients will receive oral dexmedetomidine as the sole sedative agent for undergoing MRI",
                    "armGroupLabels": [
                        "Dexmedetomidine 12 mcg/kg",
                        "Dexmedetomidine 18 mcg/kg",
                        "Dexmedetomidine 24 mcg/kg"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "General anesthetic",
                    "description": "Patients will receive inhalational anesthetic to provide general anesthesia for undergoing MRI",
                    "armGroupLabels": [
                        "General anesthesia control"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "MRI motion artifact",
                    "description": "The primary outcome is qualitative evaluation of MRI motion artifact. Each MRI sequence will be graded 1-3. 1: no-mild motion artifact; 2: moderate motion artifact; 3: severe motion artifact (non-diagnostic)",
                    "timeFrame": "Immediately after the MRI scan completion"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Ramsay Sedation Score (RSS) of 4",
                    "description": "The secondary outcome is achieving a minimum Ramsay Sedation Score (RSS) of 4",
                    "timeFrame": "During and immediately after the intervention procedure. Assessments will cease once RSS return to 3"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Subjects ages 4 months to 6 years\n2. Undergoing a clinically indicated MRI with anesthesia\n\nExclusion Criteria:\n\n1. Refusal to take oral dexmedetomidine\n2. Inability to take dexmedetomidine at least 90 minutes prior to start of the MRI\n3. Known allergy to dexmedetomidine\n4. Medical contraindication to administration of dexmedetomidine\n\n   * Unstable cardiac status including life threatening arrhythmias, abnormal cardiac anatomy, significant cardiac dysfunction\n   * Current use of digoxin\n   * Moya Moya disease\n   * New onset stroke\n5. American Society of Anesthesiologists (ASA) physical status classification system \\> II\n6. Contraindications to administering sedation\n\n   * Active and uncontrolled gastroesophageal reflux\n   * Active and uncontrolled vomiting\n   * Current or recent history of apnea\n   * Active respiratory disease including pneumonia, bronchitis, respiratory syncytial virus infection, asthma exacerbation\n   * Craniofacial anomaly\n7. Unable to have MRI",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "4 Months",
            "maximumAge": "6 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Soroush Merchant, MD, MS",
                    "role": "CONTACT",
                    "phone": "816-3018595",
                    "email": "smerchant@cmh.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Soroush Merchant, MD, MS",
                    "affiliation": "Children's Mercy Hospital Kansas City",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Children's Mercy Hospital",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64108",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Soroush Merchant, MD, MS",
                            "role": "CONTACT",
                            "phone": "816-301-8595",
                            "email": "smerchant@cmh.edu"
                        },
                        {
                            "name": "Soroush Merchant, MD, MS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Kristin Leland, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "31057237",
                    "type": "BACKGROUND",
                    "citation": "Sajid B, Mohamed T, Jumaila M. A comparison of oral dexmedetomidine and oral midazolam as premedicants in children. J Anaesthesiol Clin Pharmacol. 2019 Jan-Mar;35(1):36-40. doi: 10.4103/joacp.JOACP_20_18."
                },
                {
                    "pmid": "28105598",
                    "type": "BACKGROUND",
                    "citation": "Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017 Aug;56(8):893-913. doi: 10.1007/s40262-017-0507-7."
                },
                {
                    "pmid": "14616431",
                    "type": "BACKGROUND",
                    "citation": "Anttila M, Penttila J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol. 2003 Dec;56(6):691-3. doi: 10.1046/j.1365-2125.2003.01944.x."
                },
                {
                    "pmid": "18363626",
                    "type": "BACKGROUND",
                    "citation": "Mason KP, Zurakowski D, Zgleszewski SE, Robson CD, Carrier M, Hickey PR, Dinardo JA. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth. 2008 May;18(5):403-11. doi: 10.1111/j.1460-9592.2008.02468.x. Epub 2008 Mar 18."
                },
                {
                    "pmid": "21288220",
                    "type": "BACKGROUND",
                    "citation": "Lin L, Guo X, Zhang MZ, Qu CJ, Sun Y, Bai J. Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients. Acta Anaesthesiol Scand. 2011 Mar;55(3):359-67. doi: 10.1111/j.1399-6576.2010.02392.x."
                },
                {
                    "pmid": "22277665",
                    "type": "BACKGROUND",
                    "citation": "Iirola T, Ihmsen H, Laitio R, Kentala E, Aantaa R, Kurvinen JP, Scheinin M, Schwilden H, Schuttler J, Olkkola KT. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth. 2012 Mar;108(3):460-8. doi: 10.1093/bja/aer441. Epub 2012 Jan 25."
                },
                {
                    "pmid": "22650799",
                    "type": "BACKGROUND",
                    "citation": "Lee S, Kim BH, Lim K, Stalker D, Wisemandle W, Shin SG, Jang IJ, Yu KS. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther. 2012 Dec;37(6):698-703. doi: 10.1111/j.1365-2710.2012.01357.x. Epub 2012 May 31."
                },
                {
                    "pmid": "26068206",
                    "type": "BACKGROUND",
                    "citation": "Hannivoort LN, Eleveld DJ, Proost JH, Reyntjens KM, Absalom AR, Vereecke HE, Struys MM. Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers. Anesthesiology. 2015 Aug;123(2):357-67. doi: 10.1097/ALN.0000000000000740."
                },
                {
                    "pmid": "19708909",
                    "type": "BACKGROUND",
                    "citation": "Potts AL, Anderson BJ, Warman GR, Lerman J, Diaz SM, Vilo S. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Paediatr Anaesth. 2009 Nov;19(11):1119-29. doi: 10.1111/j.1460-9592.2009.03133.x. Epub 2009 Aug 25."
                },
                {
                    "pmid": "32986820",
                    "type": "BACKGROUND",
                    "citation": "Chamadia S, Pedemonte JC, Hobbs LE, Deng H, Nguyen S, Cortinez LI, Akeju O. A Pharmacokinetic and Pharmacodynamic Study of Oral Dexmedetomidine. Anesthesiology. 2020 Dec 1;133(6):1223-1233. doi: 10.1097/ALN.0000000000003568."
                },
                {
                    "pmid": "18578110",
                    "type": "BACKGROUND",
                    "citation": "Dashiff CJ, Weaver M. Development and testing of a scale to measure separation anxiety of parents of adolescents. J Nurs Meas. 2008;16(1):61-80. doi: 10.1891/1061-3749.16.1.61."
                },
                {
                    "pmid": "29636599",
                    "type": "BACKGROUND",
                    "citation": "Keles S, Kocaturk O. Comparison of oral dexmedetomidine and midazolam for premedication and emergence delirium in children after dental procedures under general anesthesia: a retrospective study. Drug Des Devel Ther. 2018 Mar 28;12:647-653. doi: 10.2147/DDDT.S163828. eCollection 2018."
                },
                {
                    "pmid": "1616162",
                    "type": "BACKGROUND",
                    "citation": "Weldon BC, Watcha MF, White PF. Oral midazolam in children: effect of time and adjunctive therapy. Anesth Analg. 1992 Jul;75(1):51-5. doi: 10.1213/00000539-199207000-00010."
                },
                {
                    "pmid": "16324031",
                    "type": "BACKGROUND",
                    "citation": "Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Paediatr Anaesth. 2005 Dec;15(12):1098-104. doi: 10.1111/j.1460-9592.2005.01660.x."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "All IPD that underlie results",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "Starting 6 months after publication"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000020927",
                    "term": "Dexmedetomidine"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006993",
                    "term": "Hypnotics and Sedatives"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000058647",
                    "term": "Adrenergic alpha-2 Receptor Agonists"
                },
                {
                    "id": "D000000316",
                    "term": "Adrenergic alpha-Agonists"
                },
                {
                    "id": "D000000322",
                    "term": "Adrenergic Agonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "asFound": "Traditional",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22662",
                    "name": "Dexmedetomidine",
                    "asFound": "Twice daily",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "asFound": "VO2peak",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10043",
                    "name": "Hypnotics and Sedatives",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3668",
                    "name": "Adrenergic alpha-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3673",
                    "name": "Adrenergic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                }
            ]
        }
    },
    "hasResults": false
}